Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Microbiome Transplant for Vaginal Dysbiosis
NCT04855006Completed
- Sponsor
- Rigshospitalet
- Start
- Jun 2021
- Primary completion
- Jan 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, double-blind trial of vaginal flora transplant in Vaginal dysbiosis (3 arms), sponsored by Rigshospitalet. Primary endpoint: Engraftment of transplanted vaginal microbiome at 63 days. Started Jun 2021; status: completed.
02
Drugs
vaginal flora transplant
03
Conditions
Vaginal dysbiosis
Beyond the preview
Go deeper on NCT04855006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04855006.